# Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

> **NCT02945657** · PHASE2 · COMPLETED · sponsor: **Medimetriks Pharmaceuticals, Inc** · enrollment: 32 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** MM36 topical ointment, 1%

## Key facts

- **NCT ID:** NCT02945657
- **Lead sponsor:** Medimetriks Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-06-08
- **Final completion:** 2017-06-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945657, "Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02945657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*